Your browser doesn't support javascript.
loading
Influence of demographic change on the demand for radiotherapy using forecasted predictions for prostate cancer in Germany.
Sonnhoff, M; Graff, M; Paal, K; Becker, J-N; Hermann, R-M; Christiansen, H; Nitsche, M; Merten, R.
Afiliação
  • Sonnhoff M; Department of Radiotherapy and Special Oncology, Hannover Medical School, 30625, Hannover, Germany. Sonnhoff.Mathias@mh-hannover.de.
  • Graff M; Center for Radiotherapy and Radiooncology Bremen and Westerstede, 28239, Bremen, Germany. Sonnhoff.Mathias@mh-hannover.de.
  • Paal K; Center for Radiotherapy and Radiooncology Bremen and Westerstede, 28239, Bremen, Germany.
  • Becker JN; Depatment für Radiotherapy University Hospital Graz, 8036, Graz, Austria.
  • Hermann RM; Department of Radiotherapy and Special Oncology, Hannover Medical School, 30625, Hannover, Germany.
  • Christiansen H; Department of Radiotherapy and Special Oncology, Hannover Medical School, 30625, Hannover, Germany.
  • Nitsche M; Center for Radiotherapy and Radiooncology Bremen and Westerstede, 28239, Bremen, Germany.
  • Merten R; Department of Radiotherapy and Special Oncology, Hannover Medical School, 30625, Hannover, Germany.
Strahlenther Onkol ; 2023 Aug 28.
Article em En | MEDLINE | ID: mdl-37638976
ABSTRACT

PURPOSE:

Demographic change will lead to an increase in age-associated cancers. The demand for primary treatment, especially oncologic therapies, is difficult to predict. This work is an attempt to project the demand for radiation therapy (RT) in 2030, taking into account demographic changes using prostate cancer (PC) as an example. MATERIALS AND

METHODS:

Using the GENESIS database of the Federal Statistical Office, we retrieved demographic population projections for 2030 and retrospective demographic surveys from 1999 to 2019. Additionally, we queried incidence rates for PC in the respective age groups of 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84, and +85 years from 1999-2019 via the Federal Cancer Registry of the Robert Koch Institute. We used a regression method to determine the age-dependent correlation between the incidence of PC and the population size of the respective age group by combining the data from 1999 to 2019. This information was used to calculate the incidence rates in the age groups of the expected population for 2030 and the expected new cases of PC in 2030. Finally, we extrapolated the indications for the demand for RT based on data from the Report on Cancer Incidence in Germany from 2016.

RESULTS:

Considering a population-dependent incidence rate, an increase in new cases of PC is expected. This increase is particularly evident in the age groups of 70-74 and 80-84 years. With regards to RT, the estimate indicates an overall increase of 27.4% in demand. There is also a shift in RT demands towards older patients, especially in the 80- to 84-year-old age group.

CONCLUSION:

We observe an age-associated increase in primary cases of PC. This is likely to result in an increased demand for RT. The exact demand cannot be predicted. However, trends can be estimated to plan for the demand. This, though, requires a good database from cancer registries.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article